Development of Multidrug-Resistance Convertors: Sense or Nonsense? Lia van ZuylenKees NooterJaap Verweij OriginalPaper Pages: 205 - 220
Studies on the Cytotoxic, Biochemical and Anti-Carcinogenic Potentials of Ninhydrin on Ehrlich Ascites Carcinoma Cell-Bearing Swiss Albino Mice S. QureshiO.A. Al-ShabanahM. Raza OriginalPaper Pages: 221 - 230
The Oral Route for the Administration of Cytotoxic Drugs: Strategies to Increase the Efficiency and Consistency of Drug Delivery Heleen A. BardelmeijerOlaf van TellingenJos H. Beijnen OriginalPaper Pages: 231 - 241
Phase II Study of Intravenous Doxil® in Malignant Pleural Mesothelioma Yun OhRoman Perez-SolerDong M. Shin OriginalPaper Pages: 243 - 245
Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma Paul M. DoddJohn A. McCaffreyDean F. Bajorin OriginalPaper Pages: 247 - 251
Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas T. ChidiacG.T. BuddR. Bukowski OriginalPaper Pages: 253 - 259
Phase II Trial of Aminocamptothecin (9-AC/DMA) in Patients with Advanced Squamous Cell Head and Neck Cancer Thomas LadFred RosenEverett Vokes OriginalPaper Pages: 261 - 263
Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors Jacqueline VukyJohn McCaffreyRobert J. Motzer OriginalPaper Pages: 265 - 267
A Phase II Trial of Etoposide, Leucovorin, 5-FU, and Interferon Alpha 2b (ELFI) + G-CSF for Patients with Pancreatic Adenocarcinoma: a Southwest Oncology Group Study (SWOG 9413) John S. MacdonaldJoth L. JacobsonRobert A. Chapman OriginalPaper Pages: 269 - 273
A North Central Cancer Treatment Group Phase II Trial of Topotecan in Relapsed Gliomas Patrick A. BurchAlbert M. BernathLoren K. Tschetter OriginalPaper Pages: 275 - 280
A Randomized Trial Comparing the Nephrotoxicity of Cisplatin/Ifosfamide-Based Combination Chemotherapy with or without Amifostine in Patients with Solid Tumors Jörg T. HartmannLüder M. FelsCarsten Bokemeyer OriginalPaper Pages: 281 - 289